Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Much Will The Chronic Pancreatitis (CP) Market Be Worth By 2029?

Over recent years, the market size for chronic pancreatitis (cp) has experienced robust growth. The market is projected to expand from $4.91 billion in 2024 to $5.23 billion in 2025, with a compound annual growth rate (CAGR) of 6.4%. Factors contributing to this growth during the historical period include a higher prevalence of alcohol consumption, an increase in smoking cases, genetic predisposition and family history, heightened awareness regarding pancreatic diseases, an uplift in diabetes cases associated with pancreatitis, rising healthcare expenditure, and enhanced accessibility to healthcare services.

There’s anticipation for substantial growth in the Chronic Pancreatitis (cp) market in the coming years with a expected market size of $6.66 billion in 2029, a compound annual growth rate (CAGR) of 6.2%. This future growth is expected to be driven by factors such as the increase in the aging population, a rising demand for enzyme replacement therapies, a growing consciousness about early diagnosis, expansion of medical infrastructure in developing markets and the advancement of novel pain management treatments. Additionally, continuous progress in pancreatitis treatment research and clinical trials are fueling the growth. Key trends for the forecast period are the use of artificial intelligence in diagnostic imaging, the application of minimally invasive surgical procedures, wearable technology for ongoing health tracking, next-generation sequencing for genetic testing, employing machine learning for tracking disease progression, and the innovation of smart diagnostic appliances.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21146&type=smp

What External And Internal Drivers Are Influencing The Chronic Pancreatitis (CP) Market?

The chronic pancreatitis market is predicted to see remarkable growth due to a heightened alcohol intake. The term “alcohol consumption” is defined as the consumption of beverages with ethanol, typically for recreational, social, or cultural events, but it can also cause dependency or health hazards when consumed in large amounts. There is an uptick in alcohol consumption largely due to factors like increased societal acceptance, urbanization, evolving lifestyles, and stress coping mechanisms, particularly among the younger demographic. Consuming alcohol induces chronic pancreatitis as it incites inflammation and impairment to the pancreatic cells, causing fibrosis, obstructions in ducts, and prolonged malfunction due to harmful metabolic waste. For example, a report from Kirin Holdings Company Limited, a beer and beverage firm based in Japan, stated that in December 2023, the total global beer consumption in 2022 increased by approximately 5.4 million kiloliters (equal to nearly 8.5 billion 633ml bottles), a rise from 2021, reaching about 192.1 million kiloliters. This surge of 2.9% was assigned to the relaxation of COVID-19 repercussions, translating to nearly 303.5 billion 633ml bottles. Consequently, the upswing in alcohol consumption is propelling the development of the chronic pancreatitis market.

What Segmentation Insights Are Provided In The Chronic Pancreatitis (CP) Market Research?

The chronic pancreatitis (cp)market covered in this report is segmented –

1) By Treatment: Analgesic; Artificial Digestive Enzyme; Protein Supplements; Steroids; Antibiotics; Other Treatments

2) By Diagnosis: Computed Tomography (CT) Scan; Magnetic Resonance Cholangiopancreatography; Ultrasound Sonography; Other Diagnosis

3) By Route Of Administration: Oral; Parenteral

4) By End User: Hospitals; Homecare; Other End Users

Subsegments:

1) By Analgesic: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs); Opioids

2) By Artificial Digestive Enzyme: Pancrelipase; Pancreatin

3) By Protein Supplements: Branched-Chain Amino Acids (BCAA); Whey Protein

4) By Steroids: Prednisone; Dexamethasone

5) By Antibiotics: Ciprofloxacin; Metronidazole

6) By Other Treatments: Endoscopic Treatment; Surgery

Which Notable Trends Are Transforming The Chronic Pancreatitis (CP) Market Outlook?

The primary focus of leading corporations in the chronic pancreatitis market is on the technological advancement of therapies such as enzyme replacement, a new treatment to combat exocrine pancreatic insufficiency (EPI) often linked to chronic pancreatitis. This therapy involves patients orally ingesting pancreatic enzymes to assist in digestion due to inadequate pancreatic function. For example, First Wave BioPharma Inc, a clinical-stage biopharmaceutical company in the US, reported the Phase 2 SPAN clinical trial results in July 2023. The trial investigated an innovative enteric microgranule delivery solution of adrulipase for treating exocrine pancreatic insufficiency (EPI) in patients with chronic pancreatitis and cystic fibrosis (CF). The medication adrulipase, a lipase enzyme derived from the Yarrowia lipolytica yeast, is an oral, non-systemic biological capsule created to break down fat molecules in the EPI patients’ digestive tract to ensure they are absorbed as nutrients.

Who Are The Leading Companies Driving The Chronic Pancreatitis (CP) Market?

Major companies operating in the chronic pancreatitis (CP) market are Pfizer, Johnson & Johnson, Merck & Co Inc, AbbVie Inc, Sanofi, Bristol-Myers Squibb, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Baxter, CSL Behring, Octapharma AG, Dr. Reddy’s Laboratories, Nestle Health Science, Cerata Pharmaceuticals, Unichem Laboratories Ltd, LGM Pharma, Aptalis Pharmaceutical Technologies, Digestive Care Inc, Akron Biotech

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/chronic-pancreatitis-cp-global-market-report

Which Geographic Regions Are Creating Strong Demand In The Chronic Pancreatitis (CP) Market?

North America was the largest region in the chronic pancreatitis (CP) market in 2024. The regions covered in the chronic pancreatitis (cp) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=21146&type=smp

Browse Through More Reports Similar to the Global Chronic Pancreatitis (CP) Market 2025, By The Business Research Company

Chronic Lower Back Pain Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/chronic-lower-back-pain-global-market-report

Chronic Obstructive Pulmonary Disease Copd Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/chronic-obstructive-pulmonary-disease-copd-treatment-global-market-report

Chronic Lymphocytic Leukemia Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/chronic-lymphocytic-leukemia-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model